Syngene Allots Shares Under Long-Term Incentive Plan, Slightly Raises Capital Base

Syngene International Ltd. ( (IN:SYNGENE) ) has provided an update.

Syngene International has approved the allotment of 729,727 equity shares to the Syngene Employee Welfare Trust under its Syngene Long Term Incentive Performance Share Plan 2023. The move modestly increases the company’s paid-up share capital and total shares outstanding, reflecting the ongoing use of equity-based incentives to align employee interests with long-term shareholder value.

Following this allotment, Syngene’s paid-up share capital has risen from Rs. 402.94 crore to Rs. 403.67 crore, with the total number of equity shares increasing from 40,29,39,420 to 40,36,69,147. This incremental dilution is typical of employee share plans and signals continued emphasis on talent retention and performance-linked rewards in a competitive life sciences services market.

More about Syngene International Ltd.

Syngene International Ltd. is an India-based contract research and manufacturing organization serving the global pharmaceutical, biotechnology and life sciences industries. The company provides discovery, development and manufacturing services, supporting clients with integrated solutions across the research-to-commercialization value chain.

Average Trading Volume: 162,441

Technical Sentiment Signal: Sell

Current Market Cap: 176.4B INR

For an in-depth examination of SYNGENE stock, go to TipRanks’ Overview page.